News archive

Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.

AI offers the greatest potential to transform health systems from being reactive to proactive, predictive, and even preventive.

Blood diseases place a huge burden on individual patients, their families and on wider society. Yet advances in hematology treatment give so much cause for hope. It’s our responsibility to turn that hope into reality. Hear from five bold advocates who inspire us.

At Novartis, we aim to be a leader in environmental sustainability and a catalyst for positive change both in our own operations and in our supply chain.

European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.

Novartis revealed the healthcare and pharma industry has emerged as a desired career destination for tech talent during the COVID-19 pandemic, in the Powerful Pairing research report launched today.

Standing by people with sickle cell disease and their families

COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.

Together in spirit. Find out how our associates all over the world are joining together to make a difference as we celebrate Pride 2020.

EPIS participants call for all stakeholders to ensure the patient voice is at the heart of the development of digital health solutions

A new AI-enabled disease management tool in China aims to improve the lives of millions of patients with heart failure.

This year, World Malaria Day is happening as countries around the world are fighting the COVID-19 pandemic.